Beijing SL Pharmaceutical Co., Ltd.

SZSE:002038.SZ

11.69 (CNY) • At close October 26, 2023
Overview | Financials

Numbers are in millions (except for per share data and ratios) CNY.

20232022202120202019201820172016201520142013201220112010200920082007200620052004200320022001
Revenue 1,008.2651,050.1651,214.8111,112.7342,029.7042,167.4721,242.0761,009.8471,156.5481,242.9521,161.7791,007.018622.772457.842390.025358.003237.531143.936118.55893.05171.05149.90532.183
Cost of Revenue 305.501156.956183.574163.422417.379448.275364.31351.265393.589372.427378.621330.306153.115106.74266.98449.03681.62653.12845.90732.45820.64711.5114.773
Gross Profit 702.763893.211,031.236949.3121,612.3251,719.197877.766658.583762.96870.525783.158676.711469.658351.1323.041308.967155.90590.80972.65160.59350.40438.39427.41
Gross Profit Ratio 0.6970.8510.8490.8530.7940.7930.7070.6520.660.70.6740.6720.7540.7670.8280.8630.6560.6310.6130.6510.7090.7690.852
Reseach & Development Expenses 163.91161.649196.147188.641128.35372.89473.68255.0292.30158.78788.38973.97259.88258.1810040.805000000
General & Administrative Expenses 12.73123.49915.54619.39823.56411.10811.2614.26412.76114.51118.28912.2395.2562.80763.87159.9178.21931.16329.18317.02511.58610.9354.914
Selling & Marketing Expenses 271.597426.799481.668496.3890.227911.164369.41783.84333.66530.38931.13134.76718.02918.9814.39811.25510.7539.50210.0349.6716.2445.2941.622
SG&A 326.701450.299497.215515.698913.79922.272380.67798.10746.42644.949.4247.00623.28521.78778.26971.17318.97240.66539.21626.69717.8316.236.535
Other Expenses -1.0299.24782.72975.5766.4-9.9910.99720.18111.93332.44419.2725.24911.40937.97710.1846.9869.6332.3440.9610.5430.693-0.0380.062
Operating Expenses 491.632711.195776.091779.9091,108.5441,050.135490.857196.177186.169147.12175.354158.824103.66793.38983.00875.67162.01841.93640.11527.41418.29316.5846.725
Operating Income 211.132263.317457.545412.881560.901681.637621.623507.181656.816780.477654.627555.09593.043281.576262.859228.997139.4557.43338.41435.31233.2121.84720.623
Operating Income Ratio 0.2090.2510.3770.3710.2760.3140.50.5020.5680.6280.5630.5510.9520.6150.6740.640.5870.3990.3240.3790.4670.4380.641
Total Other Income Expenses Net 241.497-3.9650.292-0.101-0.0132.584235.71164.95791.95589.0165.8742.452238.46161.84233.0112.68755.1977.7274.9171.529-0.0760.038-0.062
Income Before Tax 452.628259.352457.837412.779560.888671.646622.62527.363668.745812.415673.674560.339604.452319.553273.043235.983149.08458.18838.41435.28233.02421.84720.623
Income Before Tax Ratio 0.4490.2470.3770.3710.2760.310.5010.5220.5780.6540.580.5560.9710.6980.70.6590.6280.4040.3240.3790.4650.4380.641
Income Tax Expense 49.93731.0136.5151.32681.39108.25293.86279.97791.528111.368101.66180.36180.06143.16829.29517.55614.2597.8474.5713.2891.8262.5531.719
Net Income 416.692234.404425.94364.709486.784571.45533.575452.108575.049695.083577.397481.011523.345272.714244.105217.859134.80150.32133.82132.00231.219.29418.904
Net Income Ratio 0.4130.2230.3510.3280.240.2640.430.4480.4970.5590.4970.4780.840.5960.6260.6090.5680.350.2850.3440.4390.3870.587
EPS 0.410.230.410.360.470.830.520.440.560.680.560.470.510.270.240.220.130.0480.0340.0320.0430.0330.032
EPS Diluted 0.410.230.410.360.470.830.520.440.560.680.560.470.510.270.240.210.130.0470.0340.0320.0430.0330.032
EBITDA 356.807424.339592.335475.155642.504758.4400.398507.66617.743851.313701.011538.876388.391281.022247.064266.653144.59465.62748.38344.45741.009-16.58420.709
EBITDA Ratio 0.3540.4040.4880.4270.3170.350.3220.5030.5340.6850.6030.5350.6240.6140.6330.7450.6090.4560.4080.4780.577-0.3320.643